author-photo

Rebecca Silver

Harvard University

9

Papers

31

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Outcomes Post Neoadjuvant Intense Hormone Therapy and Surgery for Patients with High-Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials.

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (4)
Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer.

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (3)
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Post-radical prostatectomy (RP) outcome for patients with high-risk prostate cancer treated with intense neoadjuvant hormone therapy (NHT): Results of a pooled analysis of contemporary clinical trials.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Transcriptional mediators of treatment resistance in lethal prostate cancer.

2021 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (17)
Real-world utilization of radium-223 (Ra-223) for the treatment of metastatic castration-resistant prostate cancer (mCRPC): A U.S. tertiary oncology center analysis.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Response to olaparib or carboplatin in a real-world cohort of men with DNA damage repair (DDR) deficient metastatic castration-resistant prostate cancer (mCRPC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center.

2020 Prostate Cancer and Prostatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)